Previous studies showed that serum levels of LEP were significantly elevated in patients with obesity, diabetes, insulin resistance, hypertension and atherosclerosis, suggesting that LEP/LEPR might be involved in pathogenesis of above-mentioned diseases [9–11]. This evidence concerns the gene LEP and atherosclerosis.